Inventus Capital India

Inventus Capital is an experienced India-and-US early-stage venture firm with a Bengaluru base, writing Seed and Series A checks in the $1M to $5M range. The firm has a long track record across multiple Indian and US tech vintages and is known for backing ambitious Indian founders building B2B and consumer platforms with international ambition. Healthcare relevance is digital health, with the fund’s appetite skewing toward platforms, B2B health software, and consumer health products with credible Indian and international scale paths. Founders pursuing biotech, devices with multi-year clearance pathways, or care delivery brick-and-mortar should look at specialist funds. The right founder is an Indian technical or commercial operator with strong domain insight, comfortable with a fund that has lived through multiple Indian and US cycles and brings pattern recognition rather than the latest brand-name signal. Inventus is most useful when a founder values seasoned judgment and US co-investor connectivity over fund-of-the-moment hype. Geographic advantage is the bilateral India-US network, the Bengaluru talent and ecosystem reach, and partner relationships with US Series A leads that can shorten the path to international scale. Best entry is a warm intro from a portfolio founder, an Indian Tier-1 Seed fund that has co-invested with Inventus, or a US-based co-investor. Lead the pitch with revenue, cohort metrics, technical depth, and a credible international expansion plan. AI healthcare founders should describe data asset compounding, regulatory positioning under CDSCO and FDA where relevant, and how clinical or operational integration cycles work in practice. Caveats: as a longer-tenure firm, Inventus’s pace and capital deployment depend heavily on its current vintage and remaining dry powder, so founders should ask directly about fund vintage, reserves, and how follow-on is handled. The Indian early-stage market has shifted significantly across recent years, and savvy founders confirm which deals the firm has actually led recently rather than relying on legacy brand signal. Reference checks with current portfolio CEOs on operating support, US introductions, and behavior in hard rounds are particularly worth the time. Used appropriately, Inventus is a credible experienced partner for Indian digital health founders building with international ambition; founders should validate the firm’s current activity rather than rely on historical reputation alone.